chr3-50341826-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015896.4(ZMYND10):​c.1105C>T​(p.Arg369Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00637 in 1,613,930 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R369R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0051 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0065 ( 49 hom. )

Consequence

ZMYND10
NM_015896.4 missense

Scores

1
6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.04

Publications

15 publications found
Variant links:
Genes affected
ZMYND10 (HGNC:19412): (zinc finger MYND-type containing 10) This gene encodes a protein containing a MYND-type zinc finger domain that likely functions in assembly of the dynein motor. Mutations in this gene can cause primary ciliary dyskinesia. This gene is also considered a tumor suppressor gene and is often mutated, deleted, or hypermethylated and silenced in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
ZMYND10-AS1 (HGNC:40890): (ZMYND10 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00856331).
BP6
Variant 3-50341826-G-A is Benign according to our data. Variant chr3-50341826-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241067.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00508 (774/152370) while in subpopulation NFE AF = 0.00904 (615/68036). AF 95% confidence interval is 0.00845. There are 7 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015896.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZMYND10
NM_015896.4
MANE Select
c.1105C>Tp.Arg369Trp
missense
Exon 10 of 12NP_056980.2
ZMYND10
NM_001308379.2
c.1090C>Tp.Arg364Trp
missense
Exon 9 of 11NP_001295308.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZMYND10
ENST00000231749.8
TSL:1 MANE Select
c.1105C>Tp.Arg369Trp
missense
Exon 10 of 12ENSP00000231749.3
ZMYND10
ENST00000360165.7
TSL:1
c.1090C>Tp.Arg364Trp
missense
Exon 9 of 11ENSP00000353289.3
ZMYND10
ENST00000475688.1
TSL:2
n.1260C>T
non_coding_transcript_exon
Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.00509
AC:
775
AN:
152252
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00351
Gnomad FIN
AF:
0.00348
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00904
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00541
AC:
1357
AN:
251050
AF XY:
0.00555
show subpopulations
Gnomad AFR exome
AF:
0.000739
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.0104
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00389
Gnomad NFE exome
AF:
0.00857
Gnomad OTH exome
AF:
0.00490
GnomAD4 exome
AF:
0.00650
AC:
9499
AN:
1461560
Hom.:
49
Cov.:
32
AF XY:
0.00667
AC XY:
4850
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33476
American (AMR)
AF:
0.00121
AC:
54
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00968
AC:
253
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.00352
AC:
304
AN:
86252
European-Finnish (FIN)
AF:
0.00449
AC:
239
AN:
53232
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00737
AC:
8192
AN:
1111912
Other (OTH)
AF:
0.00705
AC:
426
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
642
1283
1925
2566
3208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00508
AC:
774
AN:
152370
Hom.:
7
Cov.:
33
AF XY:
0.00446
AC XY:
332
AN XY:
74518
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41594
American (AMR)
AF:
0.00137
AC:
21
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4834
European-Finnish (FIN)
AF:
0.00348
AC:
37
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00904
AC:
615
AN:
68036
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00751
Hom.:
21
Bravo
AF:
0.00427
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00779
AC:
67
ExAC
AF:
0.00568
AC:
689
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00720
EpiControl
AF:
0.00593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 11, 2025
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ZMYND10: BP4, BS2

Primary ciliary dyskinesia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T
Eigen
Benign
0.12
Eigen_PC
Benign
-0.016
FATHMM_MKL
Benign
0.65
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.0086
T
MetaSVM
Benign
-0.73
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
1.0
PrimateAI
Benign
0.41
T
PROVEAN
Pathogenic
-5.7
D
REVEL
Benign
0.16
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.60
MVP
0.15
MPC
0.41
ClinPred
0.033
T
GERP RS
2.2
Varity_R
0.29
gMVP
0.67
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142613783; hg19: chr3-50379257; COSMIC: COSV104572892; COSMIC: COSV104572892; API